Elevated Homocysteine: A Critical Risk Factor for Stroke Types and Subtypes - A Systematic Review and Meta-Analysis

Manyata Srivastava1, Annu Gulia, Pradeep Kumar

  • 1Clinical Research Unit, All India Institute of Medical Sciences, New Delhi, India.

PubMed

Insights

High homocysteine (Hcy) levels are linked to increased stroke risk. This meta-analysis confirms Hcy as a significant predictor for ischemic and hemorrhagic stroke, highlighting its potential role in stroke prevention strategies.

Area of Science:

  • Neurology
  • Cardiovascular Medicine
  • Biochemistry

Background:

  • The link between homocysteine (Hcy) and stroke risk is debated.
  • Previous investigations have yielded inconclusive results regarding this association.

Purpose of the Study:

  • To systematically review and meta-analyze studies assessing the association between elevated Hcy levels and stroke risk.
  • To investigate the relationship for stroke subtypes, including ischemic stroke (IS) and hemorrhagic stroke (HS).

Main Methods:

  • A comprehensive literature search was performed across major databases (PubMed, MEDLINE, EMBASE, Cochrane Library) up to April 2024.
  • Included case-control studies were analyzed using standardized mean difference (SMD) with 95% confidence intervals (CIs).
  • Publication bias and trial sequential analysis (TSA) were conducted to assess the robustness of findings.

Main Results:

  • Analysis of 96 studies revealed a significant association between higher Hcy levels and increased risk of IS (SMD = 1.35) and HS (SMD = 1.14).
  • Elevated Hcy levels were also significantly linked to Trial of ORG 10172 in Acute Stroke Treatment (TOAST) subtypes of IS (SMD = 1.48).
  • Trial sequential analysis confirmed sufficient statistical power for the observed associations across stroke types and subtypes.

Conclusions:

  • Elevated homocysteine levels are significantly associated with an increased risk of all stroke types and subtypes.
  • Homocysteine shows potential as a predictive biomarker for stroke risk.
  • Future research should explore hyperhomocysteinemia detection and Hcy-lowering strategies for stroke prevention.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
769
Stroke: Introduction and Types01:29

Stroke: Introduction and Types

A stroke is an acute neurological event caused by the sudden disruption of cerebral blood flow, leading to rapid loss of neuronal function. Neurons depend on continuous oxygen and glucose supply, so even brief interruptions can cause irreversible injury within minutes. Strokes are classified into ischemic and hemorrhagic types.Ischemic StrokeIschemic strokes are most common and occur due to arterial occlusion, depriving brain tissue of oxygen and nutrients. This leads to energy failure, ionic...
69
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
53
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
68
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
34
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
52